Heart Disease News and Research

Latest Heart Disease News and Research

Reform promotes patient safety by creating payment incentives, making mistakes public

The Albany Times Union: "More than a million Americans are harmed each year as a result of their medical care — not their underlying condition — and an estimated 100,000 die. Another 100,000 people die from hospital-acquired infections. In addition to expanding coverage to the uninsured, the health reform law attacks the problem of medical errors on two fronts: It establishes new payment incentives for safer care, and makes some mistakes public."

2 Apr 2010

UK researchers receive grant to study link between manmade chemicals and heart disease

The British Heart Foundation is to fund research exploring the link between Bisphenol A (BPA), a manmade chemical found in commonly used plastics, and heart disease.

2 Apr 2010

ChromaDex signs agreement for commercial development of pterostilbene from University of Mississippi and USDA

A natural products chemistry company has licensed the rights for a promising botanical compound from the University of Mississippi and the Agricultural Research Service, which is the principal intramural scientific research agency of the U.S. Department of Agriculture.

2 Apr 2010

Scientists create genetic map to identify mechanism behind heart abnormalities

Though heart disease is a major cause of disability and death, very little is understood about its genetic underpinnings. Recently, an international team of investigators at the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Sanford-Burnham Medical Research Institute (Sanford-Burnham) and other organizations shed new light on the subject.

2 Apr 2010

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

Want to find ways that may help prevent illness naturally, for a fraction of the cost of a trip to the doctor? Interested in taking control of your health with evidence-based practices that complement conventional medicine?

2 Apr 2010

AHR panel calls for greater research to establish connection between creative engagement and cardiac health

The Foundation for Art & Healing today releases the proceedings from its groundbreaking Arts and the Heart Roundtable (AHR), a gathering of luminaries from the medical, arts and public health sectors regarding the connection between creative engagement and cardiac health.

2 Apr 2010

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.

2 Apr 2010

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc., the consumer healthcare subsidiary of Merck & Co., Inc., has commenced promotion of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its licensing agreement with Santarus for the over-the-counter (OTC) market in North America. The OTC heartburn market in the U.S. is estimated at approximately $1.8 billion based on data from market research firm Information Resources, Inc. and Santarus estimates.

2 Apr 2010

Gene therapy improve survival rates among heart attack patients

Gene therapy could be an effective way to improve survival rates among heart attack patients, new research funded by the British Heart Foundation (BHF) suggests. Academics at the University of Bristol found that boosting levels of a natural growth factor in the heart could help the muscle to recover after a heart attack. The death rate from a heart attack was halved in mice that received the treatment.

1 Apr 2010

Young mother dies of post-liver transplant complications in Singapore

Claire Murray, a 25 year old woman from Perth, suffered from a liver failure due to drug addition. She underwent a controversial second live liver transplant where a part of her aunt’s liver was given to her two weeks ago. She has reportedly succumbed to her condition and died just before 12:00pm (AWST) from complications in Singapore.

1 Apr 2010

Lotus Pharmaceuticals reports EBIT increase of 29% in 2009

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China (the "PRC") reported that its 2009 net earnings were approximately $16.4 million, or $0.33 per diluted share, compared with approximately $12.8 million, or $0.27 per diluted share, in 2008. Net revenues were approximately $57.8 million in 2009 compared with $73.8 million in 2008.

1 Apr 2010

Neogen announces acquisition of GeneSeek

Neogen Corporation announced today that it had purchased all the outstanding shares of GeneSeek, Inc., of Lincoln, Neb. GeneSeek is considered the leading commercial agricultural genetics laboratory in the United States.

1 Apr 2010

ARCA biopharma raises $6.8M through sale of 1,075,000 common stock shares

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.

1 Apr 2010

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, today announced that it has signed a co-promotion agreement for Zipsor™ (diclofenac potassium) Liquid Filled Capsules with Ferring Pharmaceuticals Inc., a global bio-pharmaceutical company, headquartered in Switzerland.

1 Apr 2010

Implementation of wait time guarantees: Unfulfilled promises

The Wait Time Alliance (WTA) today expressed disappointment that some jurisdictions have still not fulfilled their 2007 promise to implement wait time guarantees, and other jurisdictions have implemented guarantees that are inconsistent and weak.

1 Apr 2010

Radiology benefit management programs can protect patients from radiation exposure

Making sure patients receive the right diagnostic imaging tests at the right times in high-quality facilities significantly reduces unnecessary radiation exposure, HealthHelp chief medical officer Mark Hiatt, M.D., testified at a public meeting held by the U.S. Food and Drug Administration.

1 Apr 2010

UC Irvine Healthcare's heart failure program earns the Gold Seal of Approval

UC Irvine Healthcare's heart failure program and Stroke & Cerebrovascular Center have again earned the Gold Seal of Approval from The Joint Commission, healthcare's predominant standards-setting and accrediting body.

1 Apr 2010

PolyMedix secures $14M credit facility with Hercules Technology II

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has secured a $14 million credit facility with Hercules Technology II, L.P., an affiliate of Hercules Technology Growth Capital, Inc.

1 Apr 2010

Ensuring medication compliance in clinical trials: Pill capsules with microchips to signal ingestion

Seeking a way to confirm that patients have taken their medication, University of Florida engineering researchers have added a tiny microchip and digestible antenna to a standard pill capsule. The prototype is intended to pave the way for mass-produced pills that, when ingested, automatically alert doctors, loved ones or scientists working with patients in clinical drug trials.

1 Apr 2010

Mount Sinai Medical Center's overall revenue growth for 2009 increased by 5%

Demonstrating the fortitude to address a challenging healthcare environment, president and C.E.O. Steven D. Sonenreich has led Mount Sinai Medical Center to financial stability and successfully reinforced its image as a healthcare leader. The most recent audit posted on March 26 reports nearly $14 million in profit for 2009.

1 Apr 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Reform promotes patient safety by creating payment incentives, making mistakes public

UK researchers receive grant to study link between manmade chemicals and heart disease

ChromaDex signs agreement for commercial development of pterostilbene from University of Mississippi and USDA

Scientists create genetic map to identify mechanism behind heart abnormalities

Mayo Clinic introduces a reliable and easy-to-understand resource on alternative medicine

AHR panel calls for greater research to establish connection between creative engagement and cardiac health

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

Schering-Plough HealthCare Products commences promotion of ZEGERID OTC in North America

Gene therapy improve survival rates among heart attack patients

Young mother dies of post-liver transplant complications in Singapore

Lotus Pharmaceuticals reports EBIT increase of 29% in 2009

Neogen announces acquisition of GeneSeek

ARCA biopharma raises $6.8M through sale of 1,075,000 common stock shares

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

Implementation of wait time guarantees: Unfulfilled promises

Radiology benefit management programs can protect patients from radiation exposure

UC Irvine Healthcare's heart failure program earns the Gold Seal of Approval

PolyMedix secures $14M credit facility with Hercules Technology II

Ensuring medication compliance in clinical trials: Pill capsules with microchips to signal ingestion

Mount Sinai Medical Center's overall revenue growth for 2009 increased by 5%

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in